NCT00346411已完成不适用
Health Outcomes in Rheumatoid Arthritis
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 164
- 试验地点
- 1
研究概览
简要总结
This research is being done to help us learn about how different factors related to treatment affect rheumatoid arthritis (RA). This is not a treatment study. We will follow the patient for one year as he or she receives usual treatment from his or her rheumatologist. Up to 360 adults with RA may join this study.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 19 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Males and females age 19 or older
- •Current active, adult-onset rheumatoid arthritis who meet American College of Rheumatology (ACR) criteria for RA and have: (ACR functional class I-III), defined as:
- •3 or more swollen or tender joints and
- •Morning stiffness of 45min or longer
- •OR judged by their rheumatologist to have active disease
- •No evidence of other inflammatory diseases (e.g., Crohn's, IBS)
- •Functional class I, II or III
排除标准
- •Individuals with significant cardiovascular disease (CHF, stroke, MI)
- •Unwilling to have medications monitored and/or comply with protocol
- •Not fluent in English
- •Planning to move from area within next year or change health insurance (which would preclude ongoing care by a Johns Hopkins rheumatologist)
- •Enrolled in study evaluating efficacy of new or existing RA medications
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Clinically Important Changes in Rheumatoid ArthritisRheumatoid ArthritisNCT00056602National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)192
已完成
不适用
Study Evaluating Health Related Utility in Rheumatoid ArthritisRheumatoid ArthritisNCT00471874Wyeth is now a wholly owned subsidiary of Pfizer250
已完成
不适用
Comparative Analysis of Outcomes Among Patients Treated With Xeljanz vs BiologicsArthritis, RheumatoidNCT03964649Pfizer7,308
招募中
3 期
Treatment of Rheumatoid Arthritis With DMARDs: Predictors of ResponseRheumatoid ArthritisNCT03414502University of Nebraska400
已完成
不适用
A Study To Investigate Markers Of Inflammation In Rheumatoid ArthritisRheumatoid ArthritisOsteoarthritisNCT00242853GlaxoSmithKline48